Your browser is no longer supported. Please, upgrade your browser.
Settings
AMRN Amarin Corporation plc daily Stock Chart
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.34 Insider Own0.90% Shs Outstand329.19M Perf Week10.51%
Market Cap5.47B Forward P/E- EPS next Y-0.17 Insider Trans0.00% Shs Float168.34M Perf Month3.42%
Income-97.80M PEG- EPS next Q-0.08 Inst Own45.40% Short Float7.91% Perf Quarter-13.89%
Sales205.80M P/S26.57 EPS this Y45.20% Inst Trans0.31% Short Ratio1.24 Perf Half Y460.20%
Book/sh-0.25 P/B- EPS next Y54.10% ROA-53.20% Target Price30.20 Perf Year304.14%
Cash/sh0.25 P/C66.76 EPS next 5Y19.90% ROE152.40% 52W Range2.35 - 23.33 Perf YTD22.04%
Dividend- P/FCF- EPS past 5Y29.10% ROI-154.70% 52W High-28.82% Beta1.15
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin75.50% 52W Low606.81% ATR1.32
Employees241 Current Ratio1.30 Sales Q/Q16.70% Oper. Margin-40.70% RSI (14)56.07 Volatility10.70% 9.40%
OptionableYes Debt/Eq- EPS Q/Q-107.10% Profit Margin-51.10% Rel Volume0.50 Prev Close16.36
ShortableYes LT Debt/Eq- EarningsJan 31 BMO Payout- Avg Volume10.77M Price16.61
Recom1.60 SMA2013.82% SMA50-2.13% SMA20091.33% Volume5,377,048 Change1.53%
Nov-14-18Upgrade Citigroup Neutral → Buy
Nov-02-18Downgrade Citigroup Buy → Neutral
Jun-27-17Resumed Cantor Fitzgerald Overweight
Oct-19-16Initiated Citigroup Buy $5
Oct-05-16Initiated Cantor Fitzgerald Buy $6
May-12-16Resumed Jefferies Buy
Mar-12-15Upgrade H.C. Wainwright Neutral → Buy $2.50 → $10
Apr-01-14Reiterated MKM Partners Neutral $1.50 → $2
Feb-24-14Reiterated MKM Partners Neutral $2.50 → $1.75
Jan-16-14Downgrade MKM Partners Buy → Neutral $2.50
Nov-08-13Reiterated MKM Partners Buy $5 → $2.50
Oct-30-13Initiated FBR Capital Mkt Perform $2
Oct-17-13Reiterated MKM Partners Buy $9 → $5
Oct-17-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
Oct-17-13Downgrade Aegis Capital Buy → Hold
Mar-20-13Initiated Chardan Capital Markets Hold $8.50
Dec-10-12Reiterated Aegis Capital Buy $25 → $35
Dec-07-12Reiterated Aegis Capital Buy $25 → $35
Jul-12-11Initiated MKM Partners Buy $23
Apr-25-11Reiterated Wedbush Outperform $12 → $18
Jan-14-19 10:45PM  Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019 Motley Fool
11:57AM  Sell Amarin Stock on the Recent Takeover Rumors Rally InvestorPlace
Jan-12-19 12:00PM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jan-11-19 10:31AM  Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference CNBC
09:56AM  Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer Zacks
Jan-10-19 04:33PM  Why Aurora Cannabis, Amarin, and Constellation Brands Jumped Today Motley Fool +22.09%
04:13PM  Will Pfizer Join The Buying Spree With This Small Biotech Stock? Investor's Business Daily
01:15PM  Amarin Corporation's Stock Heats Up on Buyout Chatter Motley Fool
07:00AM  Biotech Companies to Watch ACCESSWIRE
Jan-09-19 05:02PM  Here's Why Amarin Stock Surged Today Motley Fool +8.05%
Jan-07-19 10:06AM  Amarin Down on Lower '19 View, Posts Preliminary '18 Results Zacks +6.59%
08:33AM  2 Healthcare Stocks to Buy This Week Motley Fool
06:50AM  Today's Research Reports on Trending Tickers: Amarin Corporation and Sage Therapeutics ACCESSWIRE
Jan-04-19 04:15PM  Amarin Provides Preliminary 2018 Results and 2019 Outlook GlobeNewswire
Jan-03-19 05:51PM  The Top Healthcare Stocks of 2018: Can They Continue in 2019? Motley Fool
Jan-02-19 08:17AM  These 3 Stocks Turned $1,000 Into $7,000 -- in Just 1 Year! Motley Fool
06:00AM  Amarin to Present at 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 GlobeNewswire
Dec-31-18 08:49AM  The Most Promising Biotech Names Heading Into 2019 Investopedia
Dec-26-18 01:20PM  4 Pharma Stocks Heating Up On Wednesday (12/26/18) ACCESSWIRE +12.65%
10:32AM  3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool
Dec-24-18 10:08AM  Health care going negative after starting quarter strong CNBC Videos -6.20%
07:30AM  Biotech Breakout Candidates ACCESSWIRE
Dec-19-18 05:50PM  Amarin (AMRN) Gains As Market Dips: What You Should Know Zacks
Dec-18-18 09:19AM  Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018 Motley Fool
Dec-17-18 07:00AM  Today's Research Reports on Trending Tickers: Amarin Corporation and Agenus ACCESSWIRE
Dec-13-18 04:02AM  Here is What Hedge Funds Think About Amarin Corporation plc (AMRN) Insider Monkey
Dec-10-18 03:12PM  Here's Why Amarin Fell 13.6% in November Motley Fool
Dec-07-18 07:00AM  Today's Research Reports on Trending Tickers: Amarin Corporation and Agios Pharmaceuticals ACCESSWIRE -6.00%
Dec-03-18 05:50PM  Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know Zacks
02:00PM  2 Biotech Stocks Poised for Big Gains in 2019 Motley Fool
07:00AM  Today's Research Reports on Trending Tickers: Immunomedics and Amarin ACCESSWIRE
Nov-30-18 10:23AM  Serious Questions Surround CV Sciences Stock InvestorPlace
Nov-28-18 06:25PM  Amarin to Participate in a Fireside Chat at Citis 2018 Global Healthcare Conference GlobeNewswire
08:15AM  Market Trends Toward New Normal in Amarin, BioSpecifics Technologies, Cavco Industries, Iconix Brand Group, A-Mark Precious Metals, and Core-Mark Holding Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-27-18 04:35PM  Why U.S. Steel, Amarin, and Papa John's International Slumped Today Motley Fool -13.20%
04:20PM  Why Amarin's Latest News Caused Shares to Crash 13% Today Motley Fool
07:36AM  Stocks making the biggest move premarket: UTX, AAPL, HIBB, NVS, TSLA & more CNBC
07:32AM  The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial Benzinga
Nov-26-18 08:59PM  Amarin Prices Public Offering of American Depositary Shares GlobeNewswire
04:23PM  Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire
07:05AM  Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Amarin Corporation ACCESSWIRE
Nov-20-18 06:00AM  Amarin to Present at the Evercore ISI HealthCONx Conference GlobeNewswire
Nov-19-18 06:55AM  Today's Research Reports on Trending Tickers: Amarin and Seattle Genetics ACCESSWIRE
Nov-16-18 11:01AM  Amarin Corporation plc (NASDAQ:AMRN) Is Expected To Breakeven Simply Wall St.
Nov-15-18 06:35PM  H.C. Wainwright Sees over 80% Upside Potential for These Three Biotech Stocks SmarterAnalyst +9.93%
01:00PM  Why Amarin Corporation's Stock Is on the Mend Today Motley Fool
09:58AM  4 Stocks To Watch As Investors Dump Tech; Head To Healthcare ACCESSWIRE
08:21AM  Why Is Amarin Corporation Stock Up 300% in 2018? Motley Fool
07:00AM  Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Amarin ACCESSWIRE
06:30AM  HLS Therapeutics Announces Q3 2018 Financial Results CNW Group
Nov-14-18 07:15PM  Amarin Corp Plc (AMRN) President and CEO John F Thero Sold $11.6 million of Shares GuruFocus.com
09:33AM  Wednesdays Vital Data: Macys, Amarin and Starbucks InvestorPlace
08:35AM  3 Stock Charts for Wednesday: Home Depot, PPL and HollyFrontier InvestorPlace
Nov-13-18 04:33PM  Why Halliburton, Tyson Foods, and Amarin Slumped Today Motley Fool -22.40%
03:35PM  Here's Why Amarin Corporation Tumbled 20% Today Motley Fool
02:41PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amarin Corporation - AMRN PR Newswire
09:53AM  Amarin's Vascepa Cuts Heart Risk in Outcomes Test, Stock Down Zacks
Nov-12-18 06:03PM  As Amarin stock drops, CEO says investors should 'understand our data better' CNBC -5.84%
12:39PM  Amarin CEO comments on its new medicine's mixed results i... CNBC Videos
10:33AM  Amarin Trades Down After Release Of Late-Stage Vascepa Trial Results Benzinga
10:33AM  Why Amarin Corporation's Stock Is Falling Today Motley Fool
08:47AM  Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock? Zacks
07:00AM  Today's Research Reports on Trending Tickers: Amarin and Nektar Therapeutics ACCESSWIRE
06:30AM  HLS Therapeutics Announces that Amarin's Vascepa ® (icosapent ethyl) Demonstrates 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attack and Stroke in REDUCE-IT, which Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite Endpoint CNW Group
Nov-11-18 10:32AM  Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite Endpoint PR Newswire
Nov-10-18 03:00PM  Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite Endpoint GlobeNewswire
03:00PM  Data on Fish-Oil Pill May Justify Amarin's Surging Stock Price Bloomberg
Nov-09-18 04:29PM  Amarin's Heart-Therapy Update Seen Triggering 36% Share Move Bloomberg
Nov-08-18 09:37PM  Edited Transcript of AMRN earnings conference call or presentation 1-Nov-18 11:30am GMT Thomson Reuters StreetEvents
06:00AM  Amarin to Present at the Jefferies 2018 London Healthcare Conference GlobeNewswire
Nov-06-18 06:51PM  Cramer's lightning round: This stock could recover if the Democrats win the House CNBC
09:31AM  Tuesdays Vital Data: Activision, Amarin and Apple InvestorPlace
Nov-05-18 05:45PM  Amarin (AMRN) Gains But Lags Market: What You Should Know Zacks
Nov-04-18 07:02AM  Why Amarin Stock Jumped 28% in October -- and Why a Bigger Move Could Come Soon Motley Fool
Nov-01-18 07:51AM  Amarin (AMRN) Beats Earnings & Misses Revenues in Q3 Zacks +8.69%
05:19AM  Amarin: 3Q Earnings Snapshot Associated Press
05:00AM  Amarin Reports Third Quarter 2018 Financial Results and Provides Update on Operations GlobeNewswire
Oct-31-18 06:30AM  Fish Oil Companys 590% Boom Turns Investor Focus to Earnings Comments Bloomberg
Oct-29-18 09:56AM  What's in the Cards for Amarin (AMRN) This Earnings Season? Zacks
Oct-26-18 05:45PM  Amarin (AMRN) Gains As Market Dips: What You Should Know Zacks
05:00AM  Amarin Schedules Webcast Discussion of Primary REDUCE-IT Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association GlobeNewswire
Oct-25-18 06:00AM  Amarin To Report Third Quarter 2018 Results and Host Conference Call On November 1, 2018 GlobeNewswire
Oct-24-18 08:00AM  Today's Research Reports on Trending Tickers: Alkermes and Amarin ACCESSWIRE
Oct-23-18 08:21AM  Why Investors Are Paying a Premium for These 3 Biotech Stocks Motley Fool +8.29%
Oct-22-18 08:00AM  Today's Research Reports on Trending Tickers: Titan Pharmaceuticals and Amarin Corporation ACCESSWIRE
Oct-19-18 05:45PM  Amarin (AMRN) Dips More Than Broader Markets: What You Should Know Zacks
04:15PM  Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in January 2017 GlobeNewswire
08:45AM  Investor Expectations to Drive Momentum within Ultrapar Participacoes S.A, BioSpecifics Technologies, GSV Capital, 58, Mitel Networks, and Amarin Discovering Underlying Factors of Influence GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: Endo International and Amarin ACCESSWIRE
06:34AM  Jim Cramer Shares His Thoughts On Amarin, AT&T, McDonald's And More Benzinga
Oct-18-18 02:44PM  Up 314% in One Day ... and Then Another 58%: How to Find the Next Amarin Motley Fool
Oct-16-18 12:08PM  4 Strong Stocks to Buy That Double As Big Takeover Targets InvestorPlace
Oct-15-18 10:30AM  These Biotech and Cannabis Stocks Have Skyrocketing Potential ACCESSWIRE
Oct-12-18 08:15AM  Is Amarin Corporation PLC a Buy? Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: Amarin and Immunomedics ACCESSWIRE
Oct-10-18 05:45PM  Amarin (AMRN) Stock Moves -1.51%: What You Should Know Zacks
Oct-09-18 09:02AM  Why Amarin Stock Skyrocketed 415% in September Motley Fool -6.93%
Oct-05-18 08:00AM  Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Amarin ACCESSWIRE
Oct-04-18 08:00AM  Today's Research Reports on Trending Tickers: Amarin and Novavax ACCESSWIRE +11.48%
07:30AM  Why This Undiscovered Device Stock Could Be Worth 3x ACCESSWIRE
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. Amarin Corporation plc sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has collaboration with Mochida Pharmaceutical Co., Ltd. for the development of EPA-Based drug products and indications. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.